SOURCES_SOUGHT_NOTICE_Q0183.pdf

Sources Sought Notice

*= Required Field Sources Sought Notice

SUBJECT* 760-25-2-050-0707 -Leavenworth CMOP 11 PHARMACEUTICALS -(VA-25-00051245)

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE* 66048-5012

SOLICITATION NUMBER* 36C77025Q0183

RESPONSE DATE/TIME/ZONE 03-18-2025 16:00 CENTRAL TIME, CHICAGO, USA

ARCHIVE 60 DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS N

SET-ASIDE

PRODUCT SERVICE CODE* 6505

NAICS CODE* 325412

CONTRACTING OFFICE ADDRESS Department of Veterans Affairs

NCO 15 Contracting Ofc - CMOP 3450 S. 4th St. Trafficway

Leavenworth KS 66048-5012

POINT OF CONTACT* Contract Specialist Sarah Fry sarah.fry2@va.gov 913-758-9935

PLACE OF PERFORMANCE

ADDRESS Department of Veterans Affairs

VA CMOP Leavenworth - 760

5000 S. 13th Street Leavenworth KS

POSTAL CODE 66048-5580

COUNTRY USA

DESCRIPTION

The Department of Veterans Affairs is seeking interested sources for the requirement entitled:

CONSOLIDATED MAIL OUTPATIENT PHARMACY (CMOP)

DOMESTIC PHARMACEUTICALS

This is a Sources Sought announcement only—this is not a Request for Proposal. The purpose of this notice is to conduct market research and obtain information from qualified contractors with special interest. No solicitation is being issued at this time. This notice shall not be construed as a commitment by the Government to ultimately award a contract, nor does it restrict the Government to a particular acquisition approach.

The Government has established an ongoing requirement for the provision of domestically manufactured pharmaceuticals. In accordance with Federal Acquisition Regulation (FAR) part 15.201(c), the Agency is encouraged to promote early exchanges of information about future acquisitions. An early exchange of information in the acquisition process can identify and resolve concerns regarding the acquisition strategy, including proposed contract type, terms and conditions, and acquisition planning schedules; the feasibility of the requirement, including performance requirements, statements of work, and data requirements; the suitability of the proposal instructions and evaluation criteria, including the approach for assessing past performance information; the availability of reference documents; and any other industry concerns or questions.

The Consolidated Mail Outpatient Pharmacy program (CMOP) is seeking potential small and large business domestic pharmaceutical manufacturer or distributors capable of providing the following pharmaceuticals:

1. GALANTAMINE HYDROBROMIDE 4MG TAB 60

2. HYDROCORTISONE 2.5% OINT 30GM

3. HCTZ 25MG/VALSARTAN 320MG TAB 90CT

4. IMIQUIMOD 5% TOP CREAM PKT 0.25GM 24CT

5. LITHIUM CARBONATE 300MG 1000

6. MULTIVITAMINS W/MIN, PRENATAL CHEW TAB 100CT

7. NYSTATIN 100000 UNT/ML SUSP, 480ML

8. NEBIVOLOL 20MG TAB 90CT

9. OLANZAPINE 10MG TAB

10. PHENAZOPYRIDINE HCL 100MG TAB 100'S

11. PYRIDOSTIGMINE BROMIDE 180MG SA TAB, 30CT

The North American Industry Classification System (NAICS) code associated with this request for information is: 325412, which has a business size standard of 1,250 employees. Interested vendors are reminded that in accordance with FAR 4.12, prospective contractors shall complete electronic annual representations and certifications in conjunction with FAR 4.11 required registration in the System for Award Management (SAM) database prior to award of a contract.

DEPARTMENT OF VETERANS AFFAIRS

Veterans Health Administration

Consolidated Mail Outpatient Pharmacy (CMOP) 3450 S. 4th Street

Leavenworth, KS 66048

If you believe you are capable of meeting the requirement, please provide a response no later than MARCH 18, 2025, at 16:00 CDT to Sarah Fry at sarah.fry2@va.gov. A complete response satisfies the information requested below.

The Government requests responders provide the following information:

1) Company information including name, address, point of contact, identification of any socioeconomic categories (i.e. SDVOSB, VOSB, 8a, etc.) the company falls under, business size and DUNS Number

2) If the pharmaceutical is being manufactured domestically

3) Authorized distributors who distribute the domestically manufactured pharmaceutical(s)

4) Average cost of common prescription quantities

5) The contract number of any applicable GSA/FSS/NAC schedule if one exists from which these items can be procured under

PLEASE NOTE: This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.